News
Osteoporotic Fracture Risk Lower for DOAC Than Warfarin in A-Fib
No differences seen in fracture risk in head-to-head comparisons of direct oral anticoagulants
Your search for apixaban returned 80 results
News
Bleeding Risk Assessed With Concomitant Direct Oral Anticoagulants and Verapamil or Diltiazem
Concomitant use of dabigatran with verapamil or diltiazem was found to be associated with an increased risk of bleeding in patients with normal kidney function, according to the findings of a recently published retrospective cohort study.
News
Apixaban Seems Safer Than Rivaroxaban for A-Fib
Lower rates seen for ischemic stroke or systemic embolism, GI bleeding or intracranial hemorrhage.
Dermatological Disorders, News
Antiarrhythmic Agent Linked to Patient’s Blue-Gray Skin Discoloration
A recent report published in the New England Journal of Medicine describes the case of a patient with persistent skin discoloration associated with the use of the antiarrhythmic agent amiodarone. The 81-year-old man presented to the emergency department after a fall, which was eventually attributed to orthostatic hypotension. His medical history included atrial fibrillation and…
News, Urological Disorders
Study IDs Meds Commonly Used in Primary Care That Should Be Dose Adjusted, Avoided in CKD
A list of medications routinely prescribed in primary care practice that should be used cautiously or avoided in patients with chronic kidney disease (CKD) was compiled in a recently published study in the Annals of Pharmacotherapy.
News
First Generics of Eliquis Receive Approval
The Food and Drug Administration (FDA) has approved the first generics of Eliquis (apixaban; Bristol-Myers Squibb and Pfizer) tablets. Apixaban, a factor Xa inhibitor, is indicated: To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation For the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism…
News
Risk for Death Cuts Benefit of Oral Anticoagulants for A-Fib
Findings seen among older patients with incident atrial fibrillation receiving warfarin or apixaban
News
Many Patients Take OTC Meds That May Interact With Apixaban
Less knowledge about OTC products with potentially serious interactions linked to increased use
News
Attorney Ads May Influence DOAC Users to Discontinue Meds Without Medical Advice
According to the findings of a recent study, attorney advertisements appear to influence patients’ decisions on modifying or discontinuing their direct oral anticoagulant (DOAC) medication prior to seeking medical advice.
News
Antithrombotic Regimens Evaluated in Patients With Nonvalvular Atrial Fibrillation After ACS or PCI
Results from the phase 4 AUGUSTUS trial, evaluating apixaban vs vitamin K antagonists in patients with nonvalvular atrial fibrillation and recent acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention.
